Designing Impactful Warnings for Sugary Drinks

NCT04382599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1078

Last updated 2021-01-25

No results posted yet for this study

Summary

The goal of this online RCT study is to examine how sugar-sweetened beverage (SSB) health warnings influence US adults' perceptions and reactions. The investigators have the following predictions:

1. SSB warnings will be perceived as more effective than the control (message topic)
2. Icon and graphic warnings will be perceived as more effective than text-only warnings (message type)

The investigators will also examine the interaction of warning topic and warning type, but have no specific hypothesis about this interaction.

Finally, the investigators will test the following predictions about the secondary outcomes:

SSB warnings (vs. control), as well as icon and graphic warnings (vs text.warnings), will lead to lower perceived product healthfulness, lower purchase intentions, and higher cognitive elaboration.

Conditions

  • Health Behavior

Interventions

BEHAVIORAL

Text warning with square background

The warning message is in white text on a black square background

BEHAVIORAL

Text warning with octagon background

The warning message is in white text on a black octagon background

BEHAVIORAL

Icon warning

The warning message in in white text on a black background, below an icon that conveys the topic the warning is about

BEHAVIORAL

Graphic warning

The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Marissa G Hall, PhD · University of North Carolina

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2019-11-04
Completion
2019-11-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04382599 on ClinicalTrials.gov